Biotech stocks are among the few industry groups producing breakouts and buyable stocks in an uncertain market. Vertex stock ...
Shares in Vertex have soared after the company announced ... of up to 13.3 and 13.8 percentage points from baseline through four weeks of treatment for the triple combination regimens with VX ...
There’s a lot to be optimistic about in the Technology sector as 2 analysts just weighed in on Vertex (VERX – Research Report) and AppLovin ...
Goldman Sachs analyst expects positive updates from Vertex's first Investor Day as a public company on March 19, reiterates ...
JMP Securities analyst Patrick Walravens maintained a Buy rating on Vertex (VERX – Research Report) today and set a price target of $61.00. The ...